Keyphrases
Cyclophosphamide
100%
Advanced Ovarian Carcinoma
100%
Chemoimmunotherapy
100%
Adjuant
50%
Ovarian Cancer Patients
50%
Macrophages
50%
Relapse Risk
50%
Stage IV Disease
50%
Patient Accrual
50%
Immunostimulant
50%
High Risk
50%
Stage III Disease
50%
Adjuvant Radiation Therapy
50%
BCG Treatment
50%
Advanced Ovarian Cancer
50%
Patient Observation
50%
Local Effects
50%
5-year Survival
50%
Clonogenic Cells
50%
Effective Combination
50%
Chemotherapy Adjuvant
50%
Single-agent Chemotherapy
50%
BCG Immunotherapy
50%
Aggressive Surgery
50%
Medicine and Dentistry
Cyclophosphamide
100%
Mycobacterium Bovis BCG
100%
Chemoimmunotherapy
100%
Chemotherapy Agent
20%
Immunostimulating Agent
20%
Adjuvant Chemotherapy
20%
Macrophage
20%
Immunology and Microbiology
Mycobacterium Bovis BCG
100%
Cyclophosphamide
100%
Immunotherapy
40%
Immunostimulant
20%
Tumor Cell
20%
Macrophage
20%
Survival Rate
20%
Pharmacology, Toxicology and Pharmaceutical Science
Cyclophosphamide
100%
Doxorubicin
100%
Immunostimulant
20%
Chemotherapy Agent
20%
Chemotherapy Regimens
20%